Citation: Rd. Toto et al., Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome, AM J NEPHR, 20(1), 2000, pp. 12-17
Authors:
Shohet, RV
Vega, GL
Anwar, A
Cigarroa, JE
Grundy, SM
Cohen, JC
Citation: Rv. Shohet et al., Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease - Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations, ART THROM V, 19(8), 1999, pp. 1975-1978
Authors:
Vega, GL
Von Bergmann, K
Grundy, SM
Blumenschein, S
Carter, NB
Laeis, P
Lindenthal, B
Von Bergmann, J
Simatupang, A
Lutjohann, D
Adams-Huet, B
Citation: Gl. Vega et al., Effect of lifibrol on the metabolism of low density lipoproteins and cholesterol, J INTERN M, 246(1), 1999, pp. 1-9
Authors:
Bersot, TP
Vega, GL
Grundy, SM
Palaoglu, KE
Atagunduz, P
Ozbayrakci, S
Gokdemir, O
Mahley, RW
Citation: Tp. Bersot et al., Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population, J LIPID RES, 40(3), 1999, pp. 432-438
Citation: Sm. Grundy et al., Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men: genetic and pharmacological evidence, J LIPID RES, 40(2), 1999, pp. 229-234